Several vector-borne and zoonotic diseases have emerged or re-emerged in Europe over these last decades. Besides climate change that influences disease risk at a regional scale, landscape changes could be responsible for local heterogeneities in disease risk. Spatial epidemiology tries to understand and predict spatial variations in disease risk by using spatial tools and spatially-explicit modelling methods. This study investigated the impact of fine-grained landscape patterns on the transmission of vector-borne and zoonotic infections in terms of habitat suitability for vectors and/or hosts and of exposure of people to infectious agents. This was studied through three human diseases emerging or at risk of re-emergence in Europe: the rodent-borne Puumala hantavirus, the tick-borne Lyme borreliosis and the mosquito-borne malaria infections. Statistical models were first used to study the relationships between environmental variables and host abundance, host prevalence, and human cases of Puumala hantavirus. Environmental factors were also combined with socio-economic factors to explain Puumala hantavirus and Lyme borreliosis incidence rates. The combination of factors explaining disease transmission and the complexity of such systems led to the development of an innovative, spatially-explicit modelling method: multi-agent simulation (MAS). The MALCAM simulation model was developed to assess the risk of malaria re-emergence in southern France and simulates spatial and temporal variations in contact rate between people and potential malaria vectors. The effect of changes in potential drivers of malaria re-emergence was also simulated. The different case studies showed that fine-grained landscape patterns influence the presence and abundance of vectors and hosts. Moreover, environmental conditions may also influence disease transmission through pathogen dispersal and the exposure of people to infectious agents. Finally, this study showed that people-vector contacts not only depend on the spatial distribution of people and potential vectors, but also on their behaviours and interactions.

Laimo boreliozė (LB) yra labiausiai paplitusi erkių platinama liga. Ligos sukėlėjus perneša Ixodes rūšies erkės. Didelį borelijų paplitimą lemia platus rezervuarinių šeimininkų ratas. Šį susirgimą gali sukelti kelios B. burgdorferi s. l. komplekso bakterijų rūšys: B. afzelii, B. garinii, B. burgdorferi sensu stricto. Šiame darbe buvo tirtos 134 Ixodes ricinus erkės nuo 8 elninių gyvūnų (4 stirnų ir 4 elnių) ir 73 erkės nuo žolės (elninių teritorijoje). Naudojant dauginės polimerazės grandininės reakcijos (PGR) medodą, 9 - iose (4,3%) iš jų buvo nustatytas užsikrėtimas Borrelia burgdorferi s. l. patogenais, septyniuose mėginiuose buvo identifikuota B. afzelii, viename - B. garinii rūšis. Viename mėginyje buvo nustatyta Borrelia spp., kuri nebuvo identifikuota. Atlikta B. burgdorferi s. l. sekų analizė pagal ospA geną, naudojantis genų banko duomenimis, atskleidė polimorfizmo lygį tarp trijų, žmogui patogeniškų Borrelia rūšių ir parodė padermių pasiskirstymą skirtingose šalyse bei šeimininkuose. Variabiliausios nustatytos B. garinii ospA geno sekos, rasta 361 variabili vieta (nukleotidų įvairovė π=0,072), aptikta 18 sekų variantų. Mažesnis variabilumas nustatytas B. burgdorferi s. s. sekose – aptiktos 266 variabilios vietos (nukleotidų įvairovė π=0,16) ir 12 sekų variantų bei B. afzelii sekose – aptiktos 257 variabilios vietos (nukleotidų įvairovė π=0,17) ir 4 sekų variantai. Didesni skirtumai buvo identifikuoti tarp B. afzelii ospA geno sekų (vidutinis genetinis atstumas... [toliau žr. visą tekstą] / Lyme borreliosis (LB) is the most common tick - born disease. The pathogens are transmitted by infected ticks belonging to a species of the genus Ixodes. The high prevalence of Borrelia is determined by a wide circle of reservoir hosts. The disease can be caused by a few bacterial species of B. burgdorferi s.l. complex, such as: B. afzelii, B. garinii and B. burgdorferi sensu stricto. 134 Ixodes ricinus ticks have been explored in the thesis, collected from 8 certine animals (4 roe deer and 4 deer) and 73 ticks collected from grass (in the territory of certine animals). Using multiplex polymerase chain reaction (PCR) method, the infection with Borrelia burgdorferi s. l. pathogens was identified in 9 (4.3%), B. afzelii was identified in seven samples, while B. garinii species was found in one of them. Borrelia spp. was found in one sample, which has not been identified. A sequence analysis B. burgdorferi s. l. implemented according to the ospA gene by using a gene bank data revealed level of polymorphism among three Borrelia species pathogenic to human and showed the distribution of strains in the different countries and hosts. The most variable gene sequences are B. garinii ospA. It is found 361 variable place (nucleotide diversity π=0,072), ant detected 18 sequence variants. Less variability found in B. burgdorferi s. s. sequences: 266 variable places are found and 12 sequence variants (nucleotide diversity π=0,16) and 257 variable places are discovered in B. afzelii... [to full text]

Lyme borreliosis is a tick-transmitted infectious disease. The causative agents are spiral-shaped bacteria and the most common sign of infection is a skin rash at the site of the tick bite. If not treated with antibiotics, the bacteria can disseminate and cause a variety of different manifestations including arthritis, carditis or neurological problems. The disease is a zoonosis and the bacteria are maintained in nature by different vertebrate reservoir host animals. In Europe, three different Borrelia genospecies cause Lyme borreliosis: B. burgdorferi, B. afzelii and B. garinii. The latter depends in part on birds as its reservoir host. B. garinii bacteria have been found in a marine enzootic infection cycle worldwide and also among terrestrial birds. This thesis suggests that passerine birds and seabirds constitute an important reservoir for B. garinii bacteria also with clinical importance. We have found bacteria very similar to Lyme borreliosis causing isolates in ticks infesting migrating passerine birds. The birds not only transport infected ticks, but are competent reservoir hosts, as measured by their ability to infect naïve ticks. Their role as a reservoir host is dependent on their foraging behavior, where ground-dwelling birds are of greater importance than other species. When comparing B. garinii isolates from Europe, the Arctic and North Pacific, and including isolates from seabirds, passerine birds, Ixodes ricinus ticks and Lyme borreliosis patients, we found that phylogenetic grouping was not necessarily dependent on geographical or biological origin. B. garinii from seabirds were very heterogeneous and found in all different groups. Therefore, the marine and the terrestrial infection cycles are likely to overlap. This was supported by the fact that B. garinii isolated from seabirds can establish a long-term infection in mice. Bacteria from the genospecies B. garinii are overrepresented among neuroborreliosis patients. Interestingly, many clinical B. garinii isolates are sensitive to human serum and have shown weak binding to the complement inhibitor protein factor H. By transforming a serum-sensitive B. garinii isolate with a shuttle vector containing the gene for the factor H binding protein OspE from complement-resistant B. burgdorferi, serum resistance could be increased. In addition, neurovirulent B. garinii strains recently isolated from neuroborreliosis patients were shown to express a factor H binding protein, not found in bacteria that had been kept in culture for a long time. This protein may contribute to the virulence of neuroborreliosis-causing B. garinii strains. When testing B. garinii isolates from Lyme borreliosis patients and seabirds for resistance to human serum, all members of the latter group were sensitive to even low levels of serum. This suggests that seabird isolates are not capable of infecting humans. In agreement with this, B. garinii isolated from seabirds do not appear to bind human factor H.

The Late Rhaetian (Late Triassic) extinction event is characterised by shelled species showing a reduction in size, and thickness, which together with changed mineralogy is thought to be as a result of increased atmospheric pCO2 levels. Similar morphological changes have been demonstrated for extant species exposed experimentally to high CO2 leading to the hypothesis that Late Triassic extinctions were linked with global ocean acidification and increased oceanic palaeotemperatures. Consequently, the aim of this present work was to test this ocean acidification hypothesis by investigating morphological changes in selected shelled fossil species across this extinction event, and attempt to correlate them with changes in environmental temperature and pCO2. The abundance, size, shell thickness and mineralogy was determined for three common species, the bivalves Liostrea hisingeri and Plagiostoma gigantea and the ostracod Ogmoconchella aspinata collected from Triassic and Jurassic rocks from two locations in southwest England. Palaeotemperature was reconstructed from examination of these fossils and from the literature and atmospheric pCO2 estimated from published accounts. The shell size of bivalves increased during periods of high pCO2 and high palaeotemperature at both locations. Ostracod carapace sizes increased at St Audrie’s Bay but decreased at Lyme Regis during periods of high pCO2, while ostracod carapace size decreased during periods of high palaeotemperature at St Audrie’s Bay. However, ostracod shell thickness increased and decreased as pCO2 increased but shows no relationship with palaeotemperature at either location. Laboratory experiments on the effect of elevated pCO2 and elevated temperature on three modern species of ostracod was carried out. Modern species Leptocythere sp. and L. castanea subjected to either elevated pCO2 or elevated temperature showed increased dissolution, however size and thickness did not significantly change. In the same experimental conditions L. lacertosa showed increased dissolution however size continued to increase, while thickness was maintained. Comparison of fossil bivalve and ostracod data to modern high pCO2 and high temperature experiments illustrates some correlations to the modern experiments results indicating high pCO2 and high palaeotemperature conditions could have been occurring during the Triassic-Jurassic boundary interval. From the evidence presented, combined with an appropriate trigger (CAMP volcanism), it can be concluded that both ocean acidification and palaeotemperature were contributing to the species adaptations identified across the Triassic-Jurassic boundary interval.

Lyme-Borreliose, die mittlerweile in der nördlichen Hemisphäre wichtigste durch Vektoren übertragene Erkrankung, wird durch Spirochäten aus der Borrelia burgdorferi sensu lato Gruppe hervorgerufen. Viele der in letzter Zeit veröffentlichten Studien haben darauf hingewiesen, dass durch Antibiotikagaben eine vollständige Erregerelimination nach Infektion nicht erreicht werden kann. Eine prophylaktische Versorgung rückt somit immer weiter in den Vordergrund des Interesses. Eine Impfung ist jedoch auch nicht unproblematisch: Untersuchungen beim Menschen haben gezeigt, dass nach zweimaliger Immunisierung im ersten Jahr lediglich 68% der Probanden geschützt waren und mit einer weiteren, sich anschließenden Immunisierung der Schutz gesteigert werden konnte. Deshalb sollte die hier an Hunden durchgeführte Studie aufzeigen, ob durch eine dreimalige Impfstoffapplikation im Verlauf der Grundimmunisierung mit kommerziell erhältlichen Impfstoffen die im Hund gebildeten Antikörperspiegel zu steigern. Ein höheres Antikörperniveau führt zu einem verzögerten Antikörperabfall und somit zu einem verlängerten Schutz. Weiterhin sollte zusätzlich das induzierte Antikörperprofil näher charakterisiert und somit auch eine Aussage über die Wirksamkeit gegenüber verschiedenen Borrelienspezies ermöglicht werden. Die im Verlauf dieser Studie durchgeführten Untersuchungen zeigen, dass zunächst eine höher als erwartete Infektionsrate für die Lyme-Borreliose in Sachsen innerhalb der Hundepopulation auftritt. Der prozentuale Anteil seropositiver Tiere beträgt 20,3%. Eine serologisch nachgewiesene Infektion steht allerdings nicht in direktem Zusammenhang mit einem Ausbruch der Erkrankung und darf demnach nicht mit der Erkrankungsrate innerhalb der Hundepopulation gleichgesetzt werden. Die bisher auf dem Markt erhältlichen und hier untersuchten Impfstoffe Merilym (B. burgdorferi s. s. Lysatimpfstoff, Merial, Deutschland), LymeVax (B. burgdorferi s. s. Lysatimpfstoff, Fort Doge, USA), Biocan (B. garinii, B. afzelii Lysatimpfstoff, Bioveta, Tschechien), ProLyme (rekombinanter Outer surface protein A (OspA) Impfstoff, Intervet, USA) und RecombitekLyme (rekombinanter OspA Impfstoff, Merial, USA) wurden in seronegativen Tieren bezüglich der induzierten Gesamtantikörper, der spezifisch gegen OspA gerichteten Antikörper und ihrer Kreuzreaktivität gegenüber heterologen Spezies untersucht, wobei der Einfluss von zwei verschiedenen Impfstrategien von besonderem Interesse war. Durch eine dreifache Antigengabe im Rahmen der Grundimmunisierung konnte nur bei zwei der untersuchten Impfstoffe (Merilym und Biocan) eine deutliche Erhöhung der Antikörperspiegel erreicht werden, die sich aber statistisch nicht signifikant von den anderen unterscheidet. Somit ist eine Umsetzung dieses Impfregimes in die Praxis nicht zu empfehlen. Es zeigt im Verlauf des Jahres bei allen Impfstoffen ein Titerabfall, sowohl bei den Gesamtantikörpern, als auch bei den OspA-Antikörpern. Mit Ausnahme von Biocan, hier sind kaum OspA-Antikörper nachweisbar, induzieren alle Impfstoffe nach der Impfung vor allem OspA-Antikörper, die jedoch sehr schnell wieder abfallen und nach einem halben Jahr nur mehr in geringem Maße nachweisbar sind. Diese OspA-Antikörper sind speziesspezifisch und nur in sehr geringem Umfang kreuzreaktiv. Diese Ergebnisse weisen auf eine Suszeptibilität der geimpften Tiere bezüglich einer Borrelieninfektion innerhalb mehrerer Monate nach Impfung hin. Es empfiehlt sich eine dritte Immunisierung nach sechs Monaten, um auch in der zweiten Jahreshälfte schützende Antikörperspiegel zu ermöglichen. Untersuchungen der Kreuzreaktivität in-vitro sprechen für eine mangelhafte Bindungsfähigkeit induzierter Impfantikörper gegenüber anderen Borrelienspezies, die in Zusammenhang mit einem geringen Schutz in-vivo gesehen werden könnten. Somit ist ein rein speziesspezifischer Impfschutz wahrscheinlich. Da vor allem in Europa eine große Borrelien-Artenvielfalt vorherrscht, deuten die hier vorgestellten Ergebnisse eine nur gegen eine Spezies gerichtete Immunität bei geimpften Hunden an. Die Notwendigkeit der Entwicklung eines neuen Impfstoffes, basierend auf einer Mischung speziesspezifischer OspA-Antigene gewonnen aus B. burgdorferi s. s., B. garinii und B. afzelii in Kombination mit weiteren Antigenen, da der Schutzmechanismus beruhend auf OspA bereits durch eine OspA-Variation seitens der Borrelien durchbrochen werden kann, wird durch die hier vorgelegten Resultate gestützt. Da ein solcher Impfstoff bisher nicht erhältlich ist und die Schutzwirkung der erhältlichen Impfung als partiell angesehen werden kann, rücken einfache, aber in der Regel zuverlässigere Methoden in den Vordergrund. Die tägliche Entfernung von Zecken ist eine wirksame Vorgehensweise, um das Infektionsrisiko zu minimieren. Auch der Einsatz akarizider Substanzen und Repellentien bietet sich an, um die Übertragung der Borreliose und weiterer, von Zecken übertragene Erreger zu unterbinden. / Lyme-Borreliose, currently the most important vector-borne disease in the northern hemisphere, is caused by spirochetes from the Borrelia burgdorferi sensu lato complex. Recently published studies have indicated that a complete eradication of the bacterium from the host’s tissue by antibiotic treatment is not possible. Therefore prophylactic measures become more important. However, vaccines are not unproblematic: studies in humans have shown that only 68% of the participants were protected after two immunizations applied during the first year, while the level of protection rose when an additional immunization was given. Therefore, the study presented here was designed to reveal whether three initial immunizations with commercial vaccines are able to raise the antibody levels in dogs. Higher antibody levels are the basis for a delayed disappearance of antibodies due to natural decay and therefore provide an extended protection from infection. Furthermore, the induced antibody profile was subject of a more precise characterization in order to draw possible conclusions about their efficacy against other Borrelia species. The results presented in this study show a higher than expected prevalence of Borrelia burgdorferi sensu lato seropositivity in dogs from Saxony. The percentage of seropositive dogs was 20.3%. Since seropositivity is not necessarily linked with the onset of the disease, this result does not describe the disease incident in the dog population. In the course of the study, commercially available vaccines, Merilym (B. burgdorferi s. s. lysate, Merial, Germany), LymeVax (B. burgdorferi s. s. lysate, Fort Dodge, USA), Biocan (B. afzelii, B. garinii lysate, Bioveta, Czech Republic), ProLyme (recombinant Outer surface protein A (OspA) with adjuvant, Intervet, USA) and RecombitekLyme (recombinant OspA without adjuvant, Merial, USA) were evaluated for induced antibody levels and the amount of OspA antibodies in seronegative dogs, in which two different vaccination schedules were of special interest. In addition the cross reaction of antibodies on heterologous antigens was analyzed. Three immunizations during the first year with two (Merilym and Biocan) of the five vaccines tested increase the vaccinal antibody levels, but this increase of antibody levels is not statistically significant. Therefore a recommendation for a third antigen application within the first six weeks after basic immunisation can not be given. All vaccine-induced antibody levels show a decrease within the first year concerning total antibody titers as well as OspA antibody titers. Except for Biocan the specificity of the initially induced antibodies by vaccination are directed mainly against OspA. These antibody titers decrease quickly resulting in minimum amounts of detectable antibodies within the period of six months. These OspA antibodies are species-specific and show only a minor cross reactivity. The results presented here suggest that vaccinated animals are susceptible for a borrelia infection within months after immunization. Therefore a third vaccination six months after the basic immunization is advisable in order to induce a long lasting protective antibody level during the period of one year. These data generated with in-vitro systems suggest that only a species-specific protection can be expected in-vivo. The species heterogeneity within Europe suggests that the vaccine available in Europe only protects from infection with the species used for vaccine preparation. These results underline the necessity to develop a new vaccine consistent of a mixture of OspA derived from at least B. burgdorferi s. s., B. garinii and B. afzelii in combination with other antigens, since protection from infection via OspA can be circumvented by minor OspA variations on the part of the borrelia. Since such a vaccine is not yet available, and therefore other methods that provide protection are necessary. Daily control of the dog and the removal of adherent ticks can help to prevent a possible infection since borrelia take at least 24 hours to migrate from the midgut of the tick to the salivary gland where they can infect the host. In addition, the use of repellent or acarizides might be helpful to avoid attachment or achieve the death of adherent ticks and therefore minimize the risk of infection with borrelia as well as other tick-borne diseases.

Host cell attachment by pathogenic bacteria can play very different roles in the course of infection. The pathogenic spirochetes Borrelia hermsii and Borrelia burgdorferi sensu lato which cause relapsing fever and Lyme disease, respectively, are transmitted by the bite of infected ticks. After transmission, these spirochetes can cause systemic infection. Relapsing fever spirochetes remain largely in the bloodstream causing febrile episodes, while Lyme disease will often colonize a variety of tissues, such as the heart, joint and nervous system, resulting in a chronic multisystemic disorder. Borrelia species have the ability to bind to various cell types, a process which plays a crucial role in pathogenesis and may influence spirochetal clearance from the bloodstream. Colonization of multiple tissues and cell types is likely promoted by the ability to bind to components found in target tissues, and many B. burgdorferi adhesins have been shown to promote attachment to a wide variety of cells and extracellular matrix components. Different Lyme disease strains have been shown to preferentially colonize certain tissues, although the basis of this tissue tropism is not well understood. In this study we found that among different Lyme disease strains, allelic variation of the adhesin DbpA contributes to variation in its in vitro binding activities raising the possibility that this variation contributes to tissue tropism in vivo. In studying B. hermsii infection, we found evidence by both histological and fluorescence in situ hybridization (FISH) analysis of tissues that indicated that red blood cells were removed by tissue resident macrophages in infected mice. Spirochetes in the spleen and liver were often visualized associated with RBCs, lending support to the hypothesis that direct interaction of B. hermsii spirochetes with RBCs leads to clearance of bacteria from the bloodstream. Our findings indicate that host cell attachment play a key role in the establishment of Lyme disease infection, and in contrast contributes to the clearance of relapsing fever infection.

Host cell binding is an essential step in colonization by many bacterial pathogens, and the Lyme disease agent, Borrelia burgdorferi, which colonizes multiple tissues, is capable of attachment to diverse cell types. Glycosaminoglycans (GAGs) are ubiquitously expressed on mammalian cells and are recognized by multiple B. burgdorferi surface proteins. We previously showed that B. burgdorferi strains differ in the particular spectrum of GAGs that they recognize, leading to differences in the cultured mammalian cell types that they efficiently bind. The molecular basis of these binding specificities remains undefined, due to the difficulty of analyzing multiple, potentially redundant cell attachment pathways and to the paucity of genetic tools for this pathogen. Complementation of a high-passage non-adherent B. burgdorferi strain reveals that the expression of DbpA, DbpB, or BBK32, is sufficient to confer efficient spirochete attachment to 293 epithelial cells. Epithelial cell attachment by DbpA and B was mediated by dermatan sulfate, while BBK32 recognized dermatan and heparan sulfate. The GAG binding properties of bacteria expressing DbpB or DbpA were distinguishable in that DbpB, but not DbpA, promoted spirochetal attachment to C6 glial cells. Furthermore, DbpA alleles from diverse Lyme disease spirochetes exhibit allelic variation with respect to binding decorin, dermatan sulfate, and epithelial cells. Targeted disruption of bbk32 resulted in decreased spirochete binding to fibronectin, GAGs, and mammalian cells. Thus, DbpA, DbpB, and BBK32 may play central but distinct roles in cell type-specific binding by Lyme disease spirochetes. This study illustrates that transformation of high-passage B. burgdorferi strains and targeted gene disruption provide a comprehensive genetic approach to analyze virulence-associated phenotypes conferred by multiple bacterial factors.

Die sichere Diagnose der Lyme-Borreliose und der Nachweis des verursachenden Spirochäten Borrelia burgdorferi bei Mensch und Tier sind problematisch. In Nordamerika ist B. burgdorferi sensu stricto (B. burgdorferi s.s.) die einzige pathogene Spezies, während in Europa und Asien mit B. garinii und B. afzelii mindestens zwei weitere pathogene Arten vorkommen. B. valaisiana, B. spielmanii und B. lusitaniae werden ebenfalls als Verursacher der Lyme-Borreliose diskutiert. Der indirekte Erregernachweis durch Detektion von Antikörpern mittels Antigen aus Borrelienlysat im Zweistufentest (ELISA und Western-Blot) gilt seit langem trotz der anspruchsvollen Interpretationskriterien als Methode der Wahl. Ein hochspezifischer ELISA mit dem synthetischen C6 Peptid als Antigenkomponente ergänzt erst seit wenigen Jahren die Diagnostik. Das C6-Peptid basiert auf der invariablen Region 6, welche eine konstante Region des ansonsten hochvariablen Borrelien-Oberflächenproteins VlsE darstellt. Nur metabolisch aktive Borrelien exprimieren VlsE/C6 Epitope im Säugetierwirt. Studien zeigten, dass C6-Antikörper mehrere Monate nach einer potenziell erfolgreichen antibiotischen Therapie deutlich messbar und langfristig absinken. In Deutschland sind ein C6-Schnelltest (4Dx®SNAP®, IDEXX Inc., USA) und ELISA (Quant C6®, IDEXX Inc., USA) für die Serodiagnostik bei Hunden erhältlich. Über die Anwendbarkeit des C6-Peptids für die kanine Borreliosediagnostik in Deutschland liegen wenige Daten vor, aber zunehmend wird der Ersatz des Zweistufentests durch das C6-Peptid diskutiert. In dieser Arbeit sollte zunächst festgestellt werden, ob potenzielle kanine Infektionen in der Routinediagnostik mit dem C6-Peptid ebenso sensitiv detektiert werden können wie mit dem Zweistufentest und ob C6-positive Hunde nach einer Antibiose mit dem deutlichen Sinken der C6 Antikörperspiegel als Zeichen eines potenziellen Therapieerfolges reagieren. Dafür wurden 510 Sera von Hunden aus verschiedenen deutschen Tierarztpraxen untersucht, wobei neben der serologischen Untersuchung eine Analyse der Vorberichte erfolgte. Eine dort angegebene, bestehende Infektion konnte in 93,3 % der Fälle serologisch nicht bestätigt werden und nur bei 3,3 % der Hunde wurden infektionsspezifische Antikörper ermittelt. Der Zweistufentest und der C6 Schnelltest wiesen hier eine vollständige Übereinstimmung auf. Unabhängig vom Vorliegen klinischer Anzeichen wurden für diese Studie C6-positive Hunde mit Antibiotika behandelt. Vier bis 18 Monaten nach der Therapie wurde von insgesamt 27 Hunden eine zweite Blutprobe untersucht. Die C6 Antikörperspiegel waren bei acht Hunden im ELISA um mindestens 50 % gesunken. Für deutliche Effekte musste aber ein ausreichend hoher initialer C6-Antikörperspiegel vorliegen. Da in Europa mindestens drei pathogene Borrelienarten vorkommen, wurde in einem murinen Infektionsmodell analysiert, ob speziesspezifische C6-Peptide von B. burgdorferi s.s., B. garinii und zwei Varianten von B. afzelii sicher Antikörper detektieren, die durch definierte experimentelle Monoinfektionen mit B. burgdorferi s.s. N40, B. garinii PBi, B. afzelii Slovakia, B. afzelii PKo, B. valaisiana, B. spielmanii oder B. lusitaniae induziert wurden. Um die erfolgreiche Infektion zu belegen, wurden murine Gewebe zur Borrelienisolation in Kulturmedien inkubiert und zusätzlich eine qPCR zum Nachweis von ospA durchgeführt. Eine PCR zur Detektion von essenziellen Plasmiden ergab, dass die B.-lusitaniae- und B.-valaisiana-Isolate nicht infektiös waren. Eine Infektion konnte durch Gewebekultur und qPCR dagegen bei mit B.-burgdorferi-s.s.-, B- garinii-, B.-afzelii- und B. spielmanii-inokulierten Mäusen belegt werden. Die Ergebnisse des C6-Peptid-ELISAs wurden mit dem des Zweistufentests als Goldstandard verglichen und die Sensitivitäten der C6-Peptide ermittelt. Diese betrug bei C6-Peptiden von B. burgdorferi s.s. und B. garinii je 100 % für B.¬burgdorferi¬s.s.¬N40, B. garinii-PBi- oder B.-afzelii-PKo-spezifische C6-Antikörper. Dagegen konnten C6-Peptide basierend auf B. afzelii nur B.-afzelii-PKo-spezifische Antikörper zu 100 % erfassen. Antikörper gegen B. afzelii Slovakia wurden von jedem C6-Peptid schlechter erfasst als Antikörper gegen B. afzelii PKo, was das Vorkommen stamm- oder isolatspezifischer C6-Antikörperfraktionen nahelegt. Die Untersuchung der 27 C6-positiven Hundesera aus der serologischen Studie ergab zudem, dass der Großteil der Sera ausschließlich gegenüber B.-burgdorferi-C6 und B.-garinii-C6 deutlich messbar reagierte. Die Eignung des C6-Peptids in praxi als ein schneller, hochspezifischer Infektionsmarker für den serologischen Nachweis bei Hunden aus Deutschland kann bestätigt werden. Allerdings kann der alleinige Nachweis von C6-Antikörpern weder einen detaillierten Vorbericht, noch den Zweistufentest auf Lysatantigen-Basis ersetzen. Seine Eignung als Marker für einen potenziellen Therapieerfolg ist nur unter definierten Bedingungen gegeben. Die divergenten Sensitivitäten verschiedener C6 Peptidsequenzen gegenüber Antikörpern von in Europa vorkommenden Borrelien-Arten und Isolaten machen deutlich, dass zukünftig weiterer, intensiver Forschungsbedarf bezüglich der Etablierung von ausreichend sensitiven C6-Testsystemen für europäische Bedürfnisse notwendig ist.

Lyme disease, the most common tick borne disease in United States, is caused by the bacterial pathogen Borrelia burgdorferi. In nature, B. burgdorferi exists in an enzootic infectious cycle between an arthropod vector and mammalian hosts. Identification and characterization of the genes essential for B. burgdorferi survival throughout its infectious cycle is an important step toward understanding the molecular mechanisms involved in B. burgdorferi pathogenesis. B. burgdorferi contains a small genome, which lacks the genes encoding for the enzymes required for de novo synthesis of amino acids, fatty acids and nucleic acid precursors. Therefore, the spirochete is dependent upon the host environment for the uptake of these essential nutrients. Purines are required for the synthesis of nucleotides for the biosynthesis of DNA and RNA. Due to the lack of de novo purine synthesis, the ability of B. burgdorferi to salvage purines from its host environments is essential to its survival. While the enzymes critical for the B. burgdorferi purine salvage pathway are known, the transporters involved in the uptake of purines from the host environments are not. The work in this thesis is focused on identification of the genes encoding purine permeases in B. burgdorferi and genetic and biochemical characterization of their functions in the infectious cycle of B. burgdorferi. Here, we demonstrate that homologous genes bbb22 and bbb23 present on circular plasmid 26 encode for purine permeases, which are important for transport of hypoxanthine, adenine and guanine. Furthermore, genes bbb22-23 together were essential for B. burgdorferi infection in mice. BBB22 and BBB23 share 78% amino acid identify. And although, individually both BBB22 and BBB23 were found to be capable of purine transport, BBB22 has higher affinity for hypoxanthine and adenine compared to BBB23. Moreover, the bbb22 gene alone was sufficient to restore mouse infectivity to spirochetes lacking both bbb22 and bbb23, whereas, bbb23 was not. Nonetheless, the spirochete loads in the tissues of mice infected with B. burgdorferi carrying bbb22 alone were significantly reduced compared to B. burgdorferi carrying both bbb22 and bbb23, demonstrating the importance of the two genes together for the spirochetes to achieve wild type levels of infection. In ticks, genes bbb22 and bbb23 were dispensable for spirochete survival but contributed to spirochete replication in fed larvae. The replication of spirochetes lacking bbb22-23 in larval ticks was restored to wild type levels by the reintroduction of the low affinity purine transporter encoded by bbb23 alone. Overall, we have identified a purine transport system in B. burgdorferi, which is essential for spirochete survival in the mammalian host and contributes to spirochete replication in the tick vector. As B. burgdorferi lacks typical virulence factors and toxins, these studies highlight the critical role of physiological functions in the virulence of this pathogen. Moreover, the BBB22-23 in vivo essential transport system may represent a novel therapeutic target to deliver antimicrobial drugs to treat Lyme disease.

The marine environment provides essential ecosystem services that are critical to the functioning of the earth’s life support system and the maintenance of human well-being. Marine Protected Areas (MPAs) are recognised as being the mechanism though which marine natural capital may be conserved. This thesis focuses on the value associated with marine conservation in a case study area, Lyme Bay, England where a ‘closed area’ was created in 2008. A review of literature spanning 20 years shows that despite sound ecological knowledge of a marine area, the reliance on traditional neo-classical economic valuations for marine spatial planning can obscure other issues pertinent to the ecosystem approach. A further valuation of the marine leisure and recreation industry shows that the industry is of economic significance and that the MPA enables the protection of the most valuable sites but has limited benefits for protecting the full resource base. In terms of ecological value, a ‘service orientated framework’ was developed to enable decision makers to understand the links between benthic species, ecological function and indirect ecosystem services. Results spatially identify which ecosystem services occur and demonstrate the value of the MPA in ensuring delivery of these ecosystem services. In relation to the social value of the MPA the research reveals that support for the MPA is strong amongst the majority of stakeholder groups. Values are expressed as the economic, environmental and social benefits of the MPA. However, there have been clear social costs of the MPA policy and these have been borne by mobile and static gear fishermen and charter boat operators. Each valuation methodology can inform decision making. Though, if ecosystem service valuation is to become a deliberative tool for marine conservation and planning, then there is a need for a larger societal discussion on what activities and trade-offs society considers acceptable.